Nonnucleoside HIV‐1 Reverse‐Transcriptase Inhibitors. Part 5. Synthesis and Anti‐hiv‐1 Activity of Novel 6‐naphthylthio HEPT Analogues.

Guang‐Fu Sun,Xu‐Xiang Chen,Fen‐Er Chen,Yue‐Ping Wang,Erik De Clercq,Jan Balzarini,Christophe Pannecouque

DOI: https://doi.org/10.1002/chin.200603163

2005-01-01

ChemInform

Abstract:AbstractFor Abstract see ChemInform Abstract in Full Text.

What problem does this paper attempt to address?

Non‐Nucleoside HIV‐1 Reverse Transcriptase Inhibitors. Part 7. Synthesis, Antiviral Activity, and 3D‐QSAR Investigations of Novel 6‐(1‐naphthoyl) HEPT Analogues.

Lei Ji,Fen‐Er Chen,Xiao‐Qing Feng,Erik De Clercq,Jan Balzarini,Christophe Pannecouque

DOI: https://doi.org/10.1002/chin.200708160

2007-01-01

ChemInform

Abstract:AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.
Non‐nucleoside HIV Reverse Transcriptase Inhibitors. Part 6. Synthesis and Anti‐HIV Activity of Novel 2‐[(arylcarbonylmethyl)thio]‐6‐arylthio DABO Analogues.

Guang‐Fu Sun,Yunyan Kuang,Fen‐Er Chen,Erik De Clercq,Jan Balzarini,Christophe Pannecouque

DOI: https://doi.org/10.1002/chin.200606162

2006-01-01

ChemInform

Abstract:For Abstract see ChemInform Abstract in Full Text.
Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors, Part 4[1]. Synthesis and Anti-HIV Activity of N -1-β-carbonyl-6-naphthyl-methyl Analogues of HEPT

Yanping He,Yunyan Kuang,Fener Chen,Suxi Wang,Lei Ji,Erik De Clercq,Jan Balzarini,Christophe Pannecouque

DOI: https://doi.org/10.1007/s00706-005-0325-8

2005-01-01

Monatshefte für Chemie

Abstract:A series of 6-naphthylmethyl substituted HEPT analogues bearing a β-carbonyl and a terminal phenyl ring or ester groups on the N-1 side chain of uracil were synthesized, and the in vitro anti-HIV activity was evaluated. Most of these HEPTs were considerably less potent and selective or inactive, only a few compounds showed moderate or high activity against HIV-1. The results demonstrated that the anti-HIV-1 activity of 6-naphthylmethyl substituted HEPT analogues was diminished or eliminated when the β-oxygen of N-1 side chain was replaced by a carbonyl group.
Nonnucleoside HIV‐1 Reverse Transcriptase Inhibitors. Part 1. Synthesis and Structure—Activity Relationship of 1‐alkoxymethyl‐5‐alkyl‐6‐naphthylmethyl Uracils As HEPT Analogues.

Ge Meng,Fen‐Er Chen,Erik De Clercq,Jan Balzarini,Christophe Pannecouque

DOI: https://doi.org/10.1002/chin.200350163

2003-01-01

ChemInform

Abstract:AbstractFor Abstract see ChemInform Abstract in Full Text.
Synthesis and Anti-Hiv Activity Evaluation of 1-[(Alkenyl or Alkynyl or Alkyloxy)methyl]-5-alkyl-6-(1-naphthoyl)-2,4-pyrimidinediones As Novel Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors.

Lei Ji,Fen-Er Chen,Bin Xie,Erik De Clercq,Jan Balzarini,Christophe Pannecouque

DOI: https://doi.org/10.1016/j.ejmech.2006.09.018

IF: 7.088

2006-01-01

European Journal of Medicinal Chemistry

Abstract:The synthesis and anti-HIV activity evaluation of a new series of 2,4-pyrimidinediones bearing a 6-(1-naphthoyl) group are described. In general, it was found that most of the title compounds showed good activities against human immunodeficiency virus type-1 (HIV-1). In particular, compound 26 displayed the most potent anti-HIV-1 activity (IC50=0.11±0.05μM), inhibiting HIV-1 replication in MT-4 cells more effectively than HEPT (by 45-fold) and DDI (by 50-fold).
Nonnucleoside HIV-1 reverse transcriptase inhibitors; part 3. Synthesis and antiviral activity of 5-alkyl-2-[(aryl and alkyloxyl-carbonylmethyl)thio]-6-(1-naphthylmethyl) pyrimidin-4(3H)-ones.

Yanping He,Fener Chen,Xiongjie Yu,Yueping Wang,Erik De Clercq,Jan Balzarini,Christophe Pannecouque

DOI: https://doi.org/10.1016/j.bioorg.2004.05.007

IF: 5.307

2004-01-01

Bioorganic Chemistry

Abstract:A series of 6-naphthylmethyl substituted S-alkylated dihydroalkoxybenzyloxopyrimidine (S-DABO) analogues with a β-carbonyl group on the C-2 side chain were synthesized. All of the new compounds were evaluated for their anti-HIV activities in MT-4 cells. The most active compound, 5-isopropyl-2-[(4′-methoxyphenylcarbonyl-methyl)thio]-6-(1-naphthylmethyl)pyrimidin- 4(3H)-one showed activity against HIV-1 and against the double mutated strain of HIV(Y181C and K103N) in the micromolar range. Furthermore, some of the compounds are active against both HIV-1 and HIV-2 in cell culture. In view of the fact that the loss of antiviral activity of these compounds when tested against S0561945 was much less pronounced than the loss of activity of typical NNRTIs, it is concluded that some of the compounds might interfere with another target or act on reverse transcriptase in a different way than the typical NNRTIs.
Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors: Part I. Synthesis and Structure-Activity Relationship of 1-Alkoxymethyl-5-alkyl-6-naphthylmethyl Uracils As HEPT Analogues.

G Meng,FE Chen,E De Clercq,J Balzarini,C Pannecouque

DOI: https://doi.org/10.1248/cpb.51.779

2003-01-01

Chemical and Pharmaceutical Bulletin

Abstract:1-alkoxymethyl-5-alkyl-6-naphthylmethyl uracils, which are novel 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) analogues, were synthesized for evaluation as selective and potent nonnucleoside human immunodeficiency virus (HIV)-1 reverse transcriptase inhibitors. The anti-HIV-1 activity of these compounds was assayed in vitro using HIV-1 infected MT-4 and CEM bioassays. The EC50, CC50 and SI were recorded and calculated. The appropriate position, especially in the 1-position of the naphthyl ring, led to dramatic increases in potency, in both MT-4 and CEM cellular assays. The most important compounds in this series, 1-ethoxymethyl-5-isopropyl-6-(1-naphthylmethyl)thymine 8l (IC50=17 nM, CC50=38332 nM, SI=2229) and 1-benzyloxymethyl-5-ethyl-6-(1-naphthylmethyl)thymine 8n (IC50=17 nM, CC50=32560 nM, SI=1889) were significantly more potent than HEPT (EC50=7.0 microM, CD50=740 microM) in the anti-HIV-1 in vitro cellular assay.
Synthesis and Anti-Hiv Activity Evaluation of 2-(5-(naphthalen-1-yl)-1,2,3-thiadiazol-4-ylthio)-n-acetamides Derivatives

Xiaofei Jiang,Peng Zhan,Xinyong Liu,Erik De Clercq

2012-01-01

Abstract:The development of novel HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs) offers the possibility of generating novel structures of increased potency. Based on the bioisosterism principle, two novel 2-(5-(naphthalen-1-yl)-1,2,3-thiadiazol-4-ylthio)-N-acetamides derivatives have been designed, synthesized and evaluated for their anti-HIV activities in MT-4 cells. The results indicate that these compounds show good activities against HIV-1. Especially, compound 9B (EC50 = 0.019 mu M) was more effective than the reference drugs nevirapine and delavirdine.
Non‐Nucleoside HIV‐1 Reverse Transcriptase Inhibitors. Part 13

Yuan‐Zhen Xiong,Fen‐Er Chen,Jan Balzarini,Erik De Clercq,Christophe Pannecouque

DOI: https://doi.org/10.1002/cbdv.200800163

2009-01-01

Abstract:Abstractmagnified imageA series of diaryltriazine derivatives modified at C(2) of the triazine ring with a fluorinated phenyl group has been synthesized and tested for the ability to inhibit HIV‐1 replication. Most of these F‐containing compounds showed low‐to‐moderate anti‐HIV activity in MT‐4 cells.
Synthesis and anti-HIV activity of 2-naphthyl substituted DAPY analogues as non-nucleoside reverse transcriptase inhibitors.

Yong-Hong Liang,Qiu-Qin He,Zhao-Sen Zeng,Zhi-Qian Liu,Xiao-Qing Feng,Fen-Er Chen,Jan Balzarini,Christophe Pannecouque,Erik De Clercq

DOI: https://doi.org/10.1016/j.bmc.2010.05.036

IF: 3.461

2010-01-01

Bioorganic & Medicinal Chemistry

Abstract:Nine newly 6-cyano-2-naphthyl substituted DAPY analogues were synthesized and evaluated as inhibitors of the HIV-1 wild-type and double mutant (K103N+Y181C) strains in this paper.
Synthesis and biological activity of naphthyl-substituted (B-ring) benzophenone derivatives as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.

Xiao-Dong Ma,Xuan Zhang,Hui-Fang Dai,Shi-Qiong Yang,Liu-Meng Yang,Shuang-Xi Gu,Yong-Tang Zheng,Qiu-Qin He,Fen-Er Chen

DOI: https://doi.org/10.1016/j.bmc.2011.06.007

IF: 3.461

2011-01-01

Bioorganic & Medicinal Chemistry

Abstract:A novel series of benzophenone derivatives with B-ring substituted by naphthyl ring has been synthesized and evaluated as non-nucleoside HIV-1 reverse transcriptase inhibitors. Most of these compounds showed good to moderate activity against wild-type HIV-1 and mutated viruses. In particular, the analogue 10i demonstrated the most potent activity against wild-type HIV-1 with an EC50 value of 4.8nM, and with a high selectivity index up to 10347.9, it also proved to be active against the HIV-1 double mutant strain A17 (K103N+Y181C) with an EC50 value of 2.1μM. In addition, the molecular modeling study was used to explore the major interactions between the potent inhibitors with the HIV-1 RT. The investigation of the structure–activity relationships may serve as an important lead for the further optimization.
Synthesis and biological evaluation of naphthyl phenyl ethers (NPEs) as novel nonnucleoside HIV-1 reverse transcriptase inhibitors.

Shuang-Xi Gu,Xuan Zhang,Qiu-Qin He,Liu-Meng Yang,Xiao-Dong Ma,Yong-Tang Zheng,Shi-Qiong Yang,Fen-Er Chen

DOI: https://doi.org/10.1016/j.bmc.2011.05.060

IF: 3.461

2011-01-01

Bioorganic & Medicinal Chemistry

Abstract:A novel series of naphthyl phenyl ether analogues (NPEs) have been synthesized and evaluated for their in vitro activities against HIV in C8166 cells. Most of the compounds exhibited moderate to excellent anti-HIV activities. Among them the most active compound 12o showed excellent activities against wild-type HIV-1 with an EC(50) value of 4.60 nM, along with moderate activities against the double mutant strain HIV-1(IIIB) A17 (K103N+Y181C) and HIV-2 strain ROD with an EC(50) value of 0.82 and 4.40 μM, respectively. Preliminary structure-activity relationship (SAR) among the newly synthesized NPEs was also investigated.
Non-nucleoside HIV-1 reverse-transcriptase inhibitors. Part 10. Synthesis and anti-HIV activity of 5-alkyl-6-(1-naphthylmethyl)pyrimidin-4(3H)-ones with a mono- or disubstituted 2-amino function as novel 'dihydro-alkoxy-benzyl-oxopyrimidine' (DABO) analogues.

Yueping Wang,Fen-Er Chen,Jan Balzarini,Erik De Clercq,Christophe Pannecouque

DOI: https://doi.org/10.1002/cbdv.200890008

2008-01-01

Chemistry & Biodiversity

Abstract:A series of structurally related 2,5-disubstituted 6-(1-naphthylmethyl)-pyrimidin-4(3H)-ones, compounds 6a-6r, were synthesized and evaluated for their in vitro anti-HIV activities in MT-4 cells. Most of the new compounds investigated showed moderate-to-good activities against wild-type HIV-1, with IC50 values in the range5.64-0.21 mu M. Compound 6d was the most potent congener (IC50=0.21 mu M, SI=724) in inhibiting HIV-1 replication, which is ca. 25 times more effective than the reference compound 2',3'-dideoxyinosine (DDI). Preliminary structure -activity relationship (SAR) studies revealed that both modulation of the amino function at C(2) and of the alkyl group at C(5) of the pyrimidine ring are crucial for high anti-HIV-1 activity.
Design, synthesis and anti-HIV evaluation of novel 5-substituted diarylpyrimidine derivatives as potent HIV-1 NNRTIs

Ping Gao,Shu Song,Zhao Wang,Lin Sun,Jian Zhang,Christophe Pannecouque,Erik De Clercq,Peng Zhan,Xinyong Liu

DOI: https://doi.org/10.1016/j.bmc.2021.116195

2021-06-01

Abstract:Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are widely used in combination therapies against HIV-1. As a continuation of our efforts to discover and develop "me-better" drugs of DAPYs, novel diarylpyrimidine derivatives were designed, synthesized and evaluated for their anti-HIV activities in MT-4 cells. All the compounds demonstrated strong inhibition activity against wide-type HIV-1 strain (IIIB) with EC50 values in the range of 2.5 nM ~ 0.93 μM. Among them, compounds IVB-5–4 and IVB-5–8 were the most potent ones which showed anti-HIV-1IIIB activity much superior than that of Nevirapine, comparable to Efavirenz and Etravirine. What's more, some compounds also showed low nanomole activity against some mutant strains such as K103N and E138K. The selected compound IVB-5–4 was also evaluated for the activity against reverse transcriptase (RT), and exhibited submicromolar IC50 values indicating that this series compounds are specific RT inhibitors. Preliminary structure–activity relationships and modeling studies of these new analogues provide valuable avenues for future molecular optimization.

biochemistry & molecular biology,chemistry, medicinal, organic
ChemInform Abstract: Non‐Nucleoside HIV‐1 Reverse Transcriptase Inhibitors. Part 11. Structural Modulations of Diaryltriazines with Potent Anti‐hiv Activity.

Yuan‐Zhen Xiong,Fen‐Er Chen,Jan Balzarini,Erik De Clercq,Christophe Pannecouque

DOI: https://doi.org/10.1002/chin.200840167

2008-01-01

ChemInform

Abstract:ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.
Discovery of Novel Amino Acids (Analogues)-Substituted Thiophene[3,2- d]pyrimidine Derivatives as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: Design, Synthesis, and Biological Evaluation

Zongji Zhuo,Zhao Wang,Lanlan Jing,Tao Zhang,Anchao Ge,Zhenzhen Zhou,Ying Liu,Xin Li,Erik De Clercq,Christophe Pannecouque,Peng Zhan,Xinyong Liu,Dongwei Kang

DOI: https://doi.org/10.3390/ijms25169028

2024-08-20

Abstract:Inspired by our previous work on the modification of diarylpyrimidine-typed non-nucleoside reverse transcriptase inhibitors (NNRTIs) and the reported crystallographic studies, a series of novel amino acids (analogues)-substituted thiophene[3,2-d]pyrimidine derivatives were designed and synthesized by targeting the solvent-exposed region of the NNRTI-binding pocket. The biological evaluation results showed that compound 5k was the most active inhibitor, exhibiting moderate-to-excellent potency against HIV-1 wild-type (WT) and a panel of NNRTI-resistant strains, with EC50 values ranging from 0.042 μM to 7.530 μM. Of special note, 5k exhibited the most potent activity against single-mutant strains (K103N and E138K), with EC50 values of 0.031 μM and 0.094 μM, being about 4.3-fold superior to EFV (EC50 = 0.132 μM) and 1.9-fold superior to NVP (EC50 = 0.181 μM), respectively. In addition, 5k demonstrated lower cytotoxicity (CC50 = 27.9 μM) and higher selectivity index values. The HIV-1 reverse transcriptase (RT) inhibition assay was further performed to confirm their binding target. Moreover, preliminary structure-activity relationships (SARs) and molecular docking studies were also discussed in order to provide valuable insights for further structural optimizations. In summary, 5k turned out to be a promising NNRTI lead compound for further investigations of treatments for HIV-1 infections.
Synthesis and biological evaluation of novel 6-substituted 5-alkyl-2-(arylcarbonylmethylthio)pyrimidin-4(3H)-ones as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.

Yue-Ping Wang,Fen-Er Chen,Erik De Clercq,Jan Balzarini,Christophe Pannecouque

DOI: https://doi.org/10.1016/j.bmc.2008.01.039

IF: 3.461

2008-01-01

Bioorganic & Medicinal Chemistry

Abstract:A novel series of 2-arylcarbonylmethylthio-6-arylmethylpyrimidin-4(3H)-ones have been synthesized and evaluated for in vitro anti-HIV activities in MT-4 cells. Most of these new compounds showed moderate to potent activities against wild-type HIV-1 with an EC50 range from 8.97μM to 0.010μM. Among them, the 6-(3,5-dimethylbenzyl) analogue 5p was identified as the most promising compound (EC50=0.010μM, SI>31,800) associated with moderate activity against the HIV-1 double mutant RT strain K103N+Y181C. The structure–activity relationships of these new congeners were further discussed.
Discovery of Diarylpyridine Derivatives As Novel Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors.

Xingtao Tian,Bingjie Qin,Hong Lu,Weihong Lai,Shibo Jiang,Kuo-Hsiung Lee,Chin Ho Chen,Lan Xie

DOI: https://doi.org/10.1016/j.bmcl.2009.07.080

2009-01-01

Abstract:Two series (4 and 5) of diarylpyridine derivatives were designed, synthesized, and evaluated for anti-HIV-1 activity. The most promising compound, 5e, inhibited HIV-1 IIIB, NL4-3, and RTMDR1 with low nanomolar EC50 values and selectivity indexes of >10,000. The results of this study indicate that diarylpyridine can be used as a novel scaffold to derive a new class of potent NNRTIs, active against both wild-type and drug-resistant HIV-1 strains.
Non-nucleoside Reverse Transcriptase Inhibitors (part 18): Synthesis and Anti-Hiv Activity of 4-Allylamino or 4-Azido Substituted Diaryltriazines.

Yuan-Zhen Xiong,Hai-Rong Hu,Fen-Er Chen,Jan Balzarini,Christophe Pannecouque,Erik de Clercq

DOI: https://doi.org/10.3321/j.issn:0513-4870.2009.02.008

2009-01-01

Abstract:Eight new diaryltriazine derivatives containing 4-allylamino and 4-azido substitutes guided by molecular docking have been designed and synthesized based on our previous work. The evaluation of HIV inhibitory activity demonstrated that all compounds were potent against HIV-1 replication. The most active compound 7c exhibited activity against HIV-1 (IC50 = 0.034 micromol x L(-1), SI = 6,475) and the double mutant strain (IC50 = 9.39 micromol x L(-1)) in the micromolar range, which was more potent than nevirapine.
5‐Alkyl‐2‐[(aryl and alkyloxycarbonylmethyl)thio]‐6‐(1‐naphthylmethyl) Pyrimidin‐4(3H)‐ones as an Unique HIV Reverse Transcriptase Inhibitors of S‐DABO Series.

Yan-Ping He,Fen-Er Chen,Guangfu Sun,Yueping Wang,Erik De Clercq,Jan Balzarini,Christophe Pannecouque

DOI: https://doi.org/10.1002/chin.200440157

2004-01-01

ChemInform

Abstract:For Abstract see ChemInform Abstract in Full Text.

Nonnucleoside HIV‐1 Reverse‐Transcriptase Inhibitors. Part 5. Synthesis and Anti‐hiv‐1 Activity of Novel 6‐naphthylthio HEPT Analogues.

Non‐Nucleoside HIV‐1 Reverse Transcriptase Inhibitors. Part 7. Synthesis, Antiviral Activity, and 3D‐QSAR Investigations of Novel 6‐(1‐naphthoyl) HEPT Analogues.

Non‐nucleoside HIV Reverse Transcriptase Inhibitors. Part 6. Synthesis and Anti‐HIV Activity of Novel 2‐[(arylcarbonylmethyl)thio]‐6‐arylthio DABO Analogues.

Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors, Part 4[1]. Synthesis and Anti-HIV Activity of N -1-β-carbonyl-6-naphthyl-methyl Analogues of HEPT

Nonnucleoside HIV‐1 Reverse Transcriptase Inhibitors. Part 1. Synthesis and Structure—Activity Relationship of 1‐alkoxymethyl‐5‐alkyl‐6‐naphthylmethyl Uracils As HEPT Analogues.

Synthesis and Anti-Hiv Activity Evaluation of 1-[(Alkenyl or Alkynyl or Alkyloxy)methyl]-5-alkyl-6-(1-naphthoyl)-2,4-pyrimidinediones As Novel Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors.

Nonnucleoside HIV-1 reverse transcriptase inhibitors; part 3. Synthesis and antiviral activity of 5-alkyl-2-[(aryl and alkyloxyl-carbonylmethyl)thio]-6-(1-naphthylmethyl) pyrimidin-4(3H)-ones.

Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors: Part I. Synthesis and Structure-Activity Relationship of 1-Alkoxymethyl-5-alkyl-6-naphthylmethyl Uracils As HEPT Analogues.

Synthesis and Anti-Hiv Activity Evaluation of 2-(5-(naphthalen-1-yl)-1,2,3-thiadiazol-4-ylthio)-n-acetamides Derivatives

Non‐Nucleoside HIV‐1 Reverse Transcriptase Inhibitors. Part 13

Synthesis and anti-HIV activity of 2-naphthyl substituted DAPY analogues as non-nucleoside reverse transcriptase inhibitors.

Synthesis and biological activity of naphthyl-substituted (B-ring) benzophenone derivatives as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.

Synthesis and biological evaluation of naphthyl phenyl ethers (NPEs) as novel nonnucleoside HIV-1 reverse transcriptase inhibitors.

Non-nucleoside HIV-1 reverse-transcriptase inhibitors. Part 10. Synthesis and anti-HIV activity of 5-alkyl-6-(1-naphthylmethyl)pyrimidin-4(3H)-ones with a mono- or disubstituted 2-amino function as novel 'dihydro-alkoxy-benzyl-oxopyrimidine' (DABO) analogues.

Design, synthesis and anti-HIV evaluation of novel 5-substituted diarylpyrimidine derivatives as potent HIV-1 NNRTIs

ChemInform Abstract: Non‐Nucleoside HIV‐1 Reverse Transcriptase Inhibitors. Part 11. Structural Modulations of Diaryltriazines with Potent Anti‐hiv Activity.

Discovery of Novel Amino Acids (Analogues)-Substituted Thiophene[3,2- d]pyrimidine Derivatives as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: Design, Synthesis, and Biological Evaluation

Synthesis and biological evaluation of novel 6-substituted 5-alkyl-2-(arylcarbonylmethylthio)pyrimidin-4(3H)-ones as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.

Discovery of Diarylpyridine Derivatives As Novel Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors.

Non-nucleoside Reverse Transcriptase Inhibitors (part 18): Synthesis and Anti-Hiv Activity of 4-Allylamino or 4-Azido Substituted Diaryltriazines.

5‐Alkyl‐2‐[(aryl and alkyloxycarbonylmethyl)thio]‐6‐(1‐naphthylmethyl) Pyrimidin‐4(3H)‐ones as an Unique HIV Reverse Transcriptase Inhibitors of S‐DABO Series.